Dr. Uzzo on Unmet Needs in Kidney Cancer

Robert G. Uzzo, MD
Published: Wednesday, Oct 04, 2017



Robert G. Uzzo, MD, chair, Surgical Oncology, G. Willing "Wing" Pepper Chair in Cancer Research, senior vice president, Physician Services, president, Fox Chase Cancer Center Medical Group, Inc., professor of surgery, Temple University Health System, Fox Chase Cancer Center, discusses pressing unmet needs for patients with kidney cancer.

Biomarkers remain to be a pressing unmet need for patients with kidney cancer because without them it is difficult to stratify risks, explains Uzzo.

It is also important to be aware that there are trade-offs with kidney cancer management. Active surveillance may also begin to play a role in this treatment landscape, states Uzzo.
 


Robert G. Uzzo, MD, chair, Surgical Oncology, G. Willing "Wing" Pepper Chair in Cancer Research, senior vice president, Physician Services, president, Fox Chase Cancer Center Medical Group, Inc., professor of surgery, Temple University Health System, Fox Chase Cancer Center, discusses pressing unmet needs for patients with kidney cancer.

Biomarkers remain to be a pressing unmet need for patients with kidney cancer because without them it is difficult to stratify risks, explains Uzzo.

It is also important to be aware that there are trade-offs with kidney cancer management. Active surveillance may also begin to play a role in this treatment landscape, states Uzzo.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions & New Answers to Optimize OutcomesAug 16, 20181.5
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x